FRST
Primis Financial Corp.
FRST has the edge over JPM overall, supported by stronger valuation and stronger fundamentals.
JPM
JPMorgan Chase & Co.
JPM has lower modeled downside risk, despite its lower overall score.
FRST Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
FRST's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like FRST.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
FRST PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 6.6x | $14.64 | — |
| Cheap | 8.9x | $19.82 | +35% |
| Forward | 9.1x | $14.64 | — |
| Fair | 13x | $28.04 | +92% |
| Expensive | 53x | $117 | +697% |
Historical ranges are pointers, not guarantees.
FRST has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
FRST Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for FRST, with profitability improving. However, they disagree widely on these estimates.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over FRST on the outlook, with more favorable valuation expectations.
FRST Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.61 | -28% |
| Q3 2026 | $2.22 | +534% |
| Q2 2026 | $2.15 | +1692% |
| Q1 2026 | $1.87 | +1069% |
| Q4 2025 | $2.49 | +$3.15 |
| Q3 2025 | $0.35 | +$0.46 |
| Q2 2025 | $0.12 | +$0.52 |
| Q1 2025 | $0.16 | +$0.78 |
| Q4 2024 | -$0.66 | -$0.28 |
FRST earned $2.22 per share over the past year, about six times what it earned the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over FRST on earnings, with more consistent year-over-year improvement.
FRST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49.2M | +20% |
| Q2 2026 | $55.8M | +29% |
| Q1 2026 | $45.6M | -22% |
| Q4 2025 | $80.9M | +109% |
| Q3 2025 | $41M | +9.9% |
| Q2 2025 | $43.2M | +21% |
| Q1 2025 | $58.7M | +65% |
| Q4 2024 | $38.8M | +20% |
FRST has the edge over JPM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 22% | +0.9 points |
| Q2 2026 | 22% | +15 points |
| Q1 2026 | 23% | -19 points |
| Q4 2025 | 45% | +128 points |
| Q3 2025 | 21% | +24 points |
| Q2 2025 | 6.9% | -1 points |
| Q1 2025 | 42% | +38 points |
| Q4 2024 | -83% | -31 points |
FRST's operating margin was 22% last quarter, up 0.9 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over FRST on profitability, with a higher operating margin.
FRST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $78.8M | +$90.2M |
| Q2 2026 | -$6M | +$35M |
| Q1 2026 | -$54.6M | -259% |
| Q3 2025 | -$11.4M | -355% |
| Q2 2025 | -$41M | -181% |
| Q1 2025 | $34.4M | +$35.4M |
| Q4 2024 | -$35.7M | -152% |
| Q3 2024 | $4.5M | +$5.4M |
FRST has the stronger cash trend. Its trailing FCF is down 42% versus its history, compared with JPM at down 229%.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
FRST Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +11K shares |
| 1 year | +0.6% | +155K shares |
| 3 years | +0.6% | +157K shares |
| 5 years | +0.7% | +165K shares |
| Available history | +1.9% | +474K shares |
FRST has 25M diluted shares, up 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over FRST on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
FRST Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.8x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.1x | Net Cash |
| Q4 2025 | -1.6x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -17.4x | Net Cash |
| Q1 2025 | -9.4x | Net Cash |
| Q3 2023 | -7.1x | Net Cash |
FRST has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
FRST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.2 | Neutral |
| Stochastic | 6.2 | Oversold |
FRST's weekly RSI is 44 (neutral) and its Stochastic is 6 (oversold).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
FRST PE vs Financial Services Sector
| Metric | FRST | Sector median | Relative |
|---|---|---|---|
| PE | 6.6x | 13x | 49% below |
| PE % | 3 | 63 | 60 pts below |
FRST has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
FRST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.2 | 3.4% below |
| 20 week MA | $15.7 | 6.7% below |
| 50 week MA | $14.6 | 0.3% above |
| 100 week MA | $12.5 | 17% above |
| 200 week MA | $11.6 | 27% above |
FRST has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 27% above its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over FRST on trend strength, trading above more of its moving averages.
FRST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.4 | $12.1 | -26% |
| 2021 | $12.1 | $15.0 | +24% |
| 2022 | $15.0 | $11.8 | -21% |
| 2023 | $11.8 | $12.7 | +7.7% |
| 2024 | $12.7 | $11.7 | -7.9% |
| 2025 | $11.7 | $13.0 | +12% |
| 2026 YTD | $13.0 | $14.6 | +12% |
FRST has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.